INS and Hypoglycemia: Since the first attempts in 1966 at pancreas transplantation and in 1974 at islets transplantation, β-cell replacement therapy has evolved to become a highly efficient procedure to restore endogenous and automated insulin secretion and protect against hypoglycemia, more effectively than any pharmacological therapy [97].